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Introduction
Various cellular functions are induced by Rho kinase (ROCK), which plays a crucial role in cytoskeleton construction. One of its inhibitors, fasudil, is a potent vasodilator that has been applied as a clinical medication for treating SAH. Currently, increasingly new effects of fasudil have been discovered, particularly in the CNS. New evidence has shown that fasudil can suppress the proliferation, migration and invasion abilities of the glioblastoma cell lines T98G and U251 [1] . Moreover, the ROCK and mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK/ERK) signalling pathways are involved in the anti-tumour effects caused by fasudil [2] . Subcutaneous injection of hydroxyfasudil improves learning and working memory, which provides new insight into improving the prognosis of Alzheimer's disease (AD) [3] . Additionally, the role of this medication in preventing neurodegeneration may be due to its contribution to promoting NSC proliferation and differentiation [4, 5] . Neuronal differentiation could improve neurological function in stroke models [6] and traumatic brain injury models [7] . Fasudil can maintain and improve neurologic functions during various internal environment disturbances, which may be due to its ability to promote neurite outgrowth [8] [9] [10] . Previous reports have shown that autophagy may be involved in neurite outgrowth and cell differentiation [11, 12] . Furthermore, using an automatic analysis of the topology of the drug network, Iorio et al found that one of the unexpected effects of fasudil is autophagy induction [13, 14] .
The Notch signalling pathway is essential for maintaining NSCs in the developing brain and plays a crucial role in NSC proliferation and differentiation [15] [16] [17] . Neurite development in vitro [18] . Hes 1, which belongs to the basic helix-loophelix family of transcription factors, plays an important role in the Notch signalling pathway [19] . Additionally, Hes 1 regulates its own expression through a feedback loop and oscillates with an approximately 2-hour periodicity [20] . Both Notch 1 and Hes 1 are repressors that a proliferating state, whereas decreasing the expression of these repressors promotes NSC differentiation and depletion [22] . Moreover, the dysfunction of the Notch signalling pathway is associated with neurodegenerative diseases such as AD [23] .
In this study, we hypothesised that fasudil would promote neurite outgrowth in C17.2 NSCs and examined whether the Notch signalling pathway and autophagy were involved in the fasudil-induced neurite outgrowth of NSCs. We found that fasudil could stimulate neurite outgrowth and neuronal differentiation in C17.2 cells through modulating Notch signalling but not autophagy.
Materials and Methods
Cell culture and reagents The C17.2 cell line, which is composed of neural stem cells that were derived from the external germinal layer of mouse cerebellum [24] , was a kind gift presented by Dr. Yuming Zhao of Capital Medical University, China. Fasudil (purity>98.0%) was purchased from Melonepharma (Dalian, China), dissolved in PBS obtained from Gibco-BRL (NY, USA). Trypsin, dimethyl sulfoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), Hoechst 33258, glutamine, the autophagy inducer rapamycin and the autophagy inhibitor 3-MA were purchased from Sigma-Aldrich (MO, USA).
95% air
Neurite outgrowth measurement periods (1, 3, 6, 12, 24 and 48 h) to analyse dose-and time-dependent neurite outgrowth. Cell morphological LDH release assay 4 per well. On the following day, the cells were exposed to various concentrations of fasudil for 24 h. The medium was collected and assayed for lactate dehydrogenase (LDH) activity using a Lactate Dehydrogenase Assay Kit (Nanjing, China). Also treatment with or without fasudil at various concentrations for 24 h, the cells were incubated with 0.2 release is measured by a coupled enzymatic reaction that results in the conversion of a tetrazolium salt into red formazan product. The amount of formazan synthesised correlates with LDH activity. The formazan product was measured using a microplate reader at 450 nm. The results are expressed as the percentage of LDH release. And the absorbance of control cells was set at 100%.
Western blot
The protein levels of Notch 1 (Cell Signaling Technology, 1:1000 dilution), Hes 1 (Cell Signaling Technology, 1:1000 dilution), the NSC marker Nestin (Abcam, 1:1000 dilution), the immature neuronal cell marker doublecortin (DCX; Cell Signaling Technology, 1:1000 dilution), the mature neuronal cell marker protein (GFAP; Cell Signaling Technology, 1:1000 dilution), and the autophagy markers P62 (Cell Signaling Technology, 1:1000 dilution) and LC3 (Cell Signaling Technology, 1:1000 dilution) in C17.2 cells were examined by western blot analysis.
Cells were harvested at the indicated time points and then incubated in radio immunoprecipitation assay lysis buffer with a protease inhibitor tablet for 30 min at 4°C. Cell lysates were centrifuged at 20,000 g at 4°C for 15 min, and the supernatant was collected and stored at -20°C for further analysis by western blot. fractionated by electrophoresis on 10% and 15% polyacrylamide gels and transferred to PVDF membranes. After the membranes were blocked in 5% skim milk at room temperature for 1 h, they were incubated with primary antibodies overnight at 4°C. Then, the membranes were incubated with secondary bodies a chemiluminescence imaging system (ChemiScope5600, CLINX) in a dark room at 24°C, and signals were minutes to permeabilize the cell membranes before the cells were blocked in normal goat serum for 1 h at room temperature. Then, the cells were incubated with primary antibodies (Nestin, 1:500 dilution; DCX, 1:400 dilution; MAP-2, 1:400 dilution; GFAP, 1:400 dilution) at 4°C overnight. Subsequently, the cells were incubated with Alexa Fluor 555-conjugated secondary antibody (1:500) for 1 h at room temperature. The Cellular Physiology and Biochemistry
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Statistical analysis
The data are presented as the means±standard error. Statistical analyses between two groups were performed using unpaired Student's t-test. Differences among groups were tested by one-way analysis of variance (ANOVA). Following ANOVA analyses, Tukey's test was used, and p<0.05 was considered statistically
Results
Fasudil induced neurite outgrowth in C17.2 cells
We examined the effect of fasudil on neurite outgrowth in C17.2 cells. After the cells were treated with fasudil for 1 h, the ratio of neurite-bearing cells obviously and rapidly a slow increase in the ratio of neurite-bearing cells in a time-dependent manner when compared with the untreated control group. However, when compared with dose-matched, untreated cells, the percentage of neurite-bearing cells rapidly increased with 1, 3, 6, 12 and 24 h of persistent treatment but mildly increased from 24 to 48 h in different concentrations of fasudil. In contrast, when compared with time-matched, untreated cells, the percentage of neurite-bearing cells increased 3.4-, 4.3-, 6.7-and 8.8-fold following stimulation with fasudil periods, the stimuli were removed, and the culture medium was returned to complete DMEM for 12 h. Then, the percentage of remaining neurite-bearing cells was calculated for dose-and time-dependent treatments with fasudil (Fig. 2) . Compared with time-matched, untreated cells, the percentage of remaining neurite-bearing cells after treatment with 100 p<0.01) at different time points. Based on these data,
Fasudil was not cytotoxic to C17.2 cells
The C17.2 cells were incubated with various concentrations of fasudil for 24 h, and then cell viability was measured by MTT assay. As shown in Fig. 3B , the net absorbance at p<0.05) 
Fasudil modulated the Notch signalling pathway
To determine whether the Notch signalling pathway was involved in fasudil-induced differentiation of NSCs, we examined the expression levels of Notch 1 and Hes 1 in C17.2 cells with or without fasudil treatment. As shown in Fig. 5 , fasudil treatment obviously tern blot analyses were applied to evaluate the levels of the neural stem cell marker Nestin (A/B), the immature neuronal marker DCX (C/D), the mature neuronal marker MAP-2 (E/F) and the astrocytic marker GFAP (G/H). ***p . Western blot analysis of the expression levels of the autophagy markers P62 and LC3 in C17.2 cells (C). *p<0.05 and ***p 12%, 61%, 49% and increased by 1% following fasudil treatment for 1, 3, 6, 12 and 24 hs, respectively, when compared with untreated cells (p<0.01, p<0.05 or no difference).
3-MA did not affect fasudil-induced neurite outgrowth in NSCs and rapamycin could not induce neurite outgrowth as fasudil did
To determine whether autophagy was involved in the observed neurite outgrowth in C17.2 cells, the autophagy inhibitor 3-MA and the autophagy inducer rapamycin were applied. Both 3-MA and rapamycin had no effect on the observed morphological changes of the cells. The percentage of neurite-bearing cells did not change after rapamycin treatment compared with that of untreated cells (Fig. 6A/B) . Additionally, no change in the ratio of neurite-bearing cells was found in the cells treated with fasudil+3-MA compared with the cells treated with fasudil alone (Fig. 6A/B) . Western blot analysis (Fig. 6C ) was used to detect the protein levels of LC3II and p62, whose levels changed as we expected; fasudil and rapamycin treatment increased the levels of LC3II and p62 expression, and 3-MA decreased these levels after treatment for 12 h.
Discussion
In this study, we examined the neurite outgrowth in C17.2 cells induced by fasudil in a dose-and time-dependent manner. Moreover, fasudil was not cytotoxic to C17.2 cells and caused these cells to differentiate into immature or mature neuronal cells and astrocytes through modulating the Notch signalling pathway. Autophagy was also potentiated in C17.2 cells by fasudil; however, no effect on neurite outgrowth was observed when autophagy was induced or inhibited.
We found that the observed neurite outgrowth could be reversed by washing off fasudil and further incubating the cells for 12 h (Fig. 1 and Fig. 2 ). The outgrowth of neurite induced by lower concentration of fasudil might be due to its Rho kinase inhibition, which plays a crucial role in cytoskeleton construction [27, 28] . Very recently, two other reports demonstrated that Rho/ROCK pathway is involved with neurite outgrowth in NT2 and PC12 cells [29, 30] . But it is interesting that why the neurite will not retract when cells exposed to high concentration of fasudil (100 µM). At such concentration, fasudil can also inhibit other kinases, including PKA [31] . Further studies are necessary to uncover the exact mechanism.
The Notch signalling pathway is widely believed to be tightly associated with NSC differentiation and proliferation. The Notch signalling pathway is activated for NSC selfrenewal, and NSCs switch from proliferation to differentiation when Notch activity decreases [16] . In our study, the expression levels of Notch 1 and Hes 1, which were examined by Western after the cells were treated with fasudil for 6 h compared with other treatment groups; this increase may be due to the oscillation of Hes 1 expression [20] . NSC differentiation and [33] and cell volume change [34] .
The Notch signalling pathway plays a crucial role in the development of the CNS and in the regulation of NSC proliferation, survival, self-renewal and differentiation, is involved in many neurodegenerative diseases such as AD and Parkinson's disease (PD) [23, 35] . Inhibiting Notch signalling to promote NSC differentiate into dopaminergic neurons may provide a cell replacement therapy for PD [35] . Additionally, down-regulating Notch 1 may reduce tau aggregates in AD to improve the cognitive function of AD patients [23] . Thus, Notch 1 is a potential therapeutic target for neurodegenerative diseases. Additionally, a fancy Notch-ROCK pathway is involved in immature cell self-renewal and differentiation [36] . Our study suggested that fasudil, which inhibits Notch signalling and the ROCK pathway, may be a promising potent strategy for treating neurodegenerative diseases.
The mechanisms involved in neurite outgrowth and NSC differentiation induced by fasudil are complicated and remain unclear. Some evidence has indicated that autophagy is involved in neurite outgrowth [37] and that fasudil can potentiate autophagy [13] . Thus, we determined whether autophagy is involved in fasudil-induced neurite outgrowth. Although fasudil and rapamycin treatment induced autophagy, only the cells treated with fasudil displayed neurite outgrowth. Furthermore, autophagy was inhibited when cells were treated with both fasudil and 3-MA; however, no effect on neurite outgrowth was observed in C17.2 cells most likely because the concentration of fasudil was so high that more than one signalling pathway was affected simultaneously. In addition, the conventional clinical dosage of fasudil is 30 mg per day, and its peak concentration in human plasma is approximately concentration of fasudil that is somewhat higher than that in vivo. Moreover, fasudil has a low blood-brain barrier transmittance due to its poor lipid solubility [39] . However, our diseases, particularly in CNS disorders.
As a clinical medicine, fasudil is primarily used to dilate arteries in SAH patients. Fasudil also plays multiple roles in disease states, such as suppressing angiogenesis to inhibit tumour growth [2] , improving neurological function recovery in neurodegenerative disease [5] and preserving the motor neurons to treat spinal and muscle atrophy [28] . Fasudil may be a multi-target medicine that regulates not only ROCK but also the ERK signal pathway [2] , and Akt [40] and Wnt signalling [41] . Thus, with multiple targets, fasudil may be a promising medicine for CNS disorders.
In summary, the present study demonstrated that fasudil stimulates neurite outgrowth in C17.2 cells and promotes their differentiate into neuronal cells through modulating Notch signalling but not autophagy, suggesting that fasudil may be a promising medicine to exert its multi-targeted activity in CNS disorder treatment.
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